Literature DB >> 18724167

Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.

Marta Galdos1, Jaime Etxebarría.   

Abstract

PURPOSE: To report the favorable outcome of a patient with severe ocular cicatricial pemphigoid, which was refractory to conventional treatment but recovered after intravenous immunoglobulin therapy.
METHODS: A case report.
RESULTS: Conventional therapy failed to control the ocular symptoms of this patient, which are typical of the disease. However, the patient improved remarkably in response to pulsed intravenous human immunoglobulin therapy.
CONCLUSIONS: We achieved stabilization of the disease around the seventh intravenous immunoglobulin cycle, thus contributing to satisfactory postoperative evolution after limbal allograft transplantation and facilitating the performance of intraocular surgical procedures, such as phacoemulsification, with improvement in best-corrected visual acuity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18724167     DOI: 10.1097/ICO.0b013e318172fbc5

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

Review 1.  The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature.

Authors:  Soheil Tavakolpour
Journal:  J Res Med Sci       Date:  2016-06-14       Impact factor: 1.852

2.  Improvement in ocular cicatricial pemphigoid following treatment for porphyria cutanea tarda.

Authors:  R Marshall Ford; Yousuf M Khalifa
Journal:  Clin Ophthalmol       Date:  2012-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.